Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division Sort descending
  • Business
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Sort descending Business Functional Area Erscheinungsdatum
Projektni inženir (m/ž/d) / Project Engineer II (m/f/d) Ljubljana Slowenien Operations Innovative Medicines Technical Operations Aug 27, 2024
Senior Developer, Generative AI Navigator (Python) Hyderabad (Office) Indien Operations CTS Technology Transformation Aug 27, 2024
Sr. Spec. DDIT IES Database Services INSURGENTES Mexiko Operations CTS Technology Transformation Aug 27, 2024
Snr. Specialist MDM (Master Data Management - implementation using Reltio) Hyderabad (Office) Indien Operations CTS Technology Transformation Aug 28, 2024
Snr Specialist(Power BI & Embedded Analytics - Web applications) Hyderabad (Office) Indien Operations CTS Technology Transformation Aug 28, 2024
Assoc. Dir Content Engineering(Azure -AWS-Application management Documentum) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Salesforce Marketing Cloud Architect( MCP OR MCI , Data Cloud) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Specialist - Quality Operations (APQR) INSURGENTES Mexiko Operations Innovative Medicines Quality Sep 27, 2024
P2P Process Excellence INSURGENTES Mexiko Operations CTS Audit und Finanzen Okt 02, 2024
Quality Operations Specialist - Batch Release INSURGENTES Mexiko Operations Innovative Medicines Quality Okt 07, 2024
Quality Assurance Specialist Murcia Spanien Operations Innovative Medicines Quality Okt 16, 2024
Ingénieur Biotech Culture Cellulaire / USP (H/F) Huningue Frankreich Operations Innovative Medicines Technical Operations Okt 02, 2024
Chef de Projet Ingénierie (h/f) Huningue Frankreich Operations Innovative Medicines Technical Operations Okt 15, 2024
Compliance & Quality System Manager Ivrea Italien Operations Innovative Medicines Quality Okt 17, 2024
Quality Control Staff Sasayama Japan Operations Innovative Medicines Quality Okt 18, 2024
Analyst - SFE Products Hyderabad (Office) Indien Operations CTS Marketing Mai 20, 2024
Manager, Value Stream Morris Plains USA Operations Innovative Medicines Technical Operations Okt 16, 2024
Sr. Manager, ITOT Site Lead Haiyan (Zhejiang Province) China Operations CTS Technology Transformation Sep 03, 2024
Labortechniker / QC Analyst II (m/w/d), Tirol, Österreich Schaftenau Österreich Operations Innovative Medicines Quality Sep 03, 2024
Senior Analyst - Competitive Social Intelligence Hyderabad (Office) Indien Operations CTS Marketing Aug 30, 2024
QC Specialist Tech Resources & Compliance Durham USA Operations Innovative Medicines Quality Sep 03, 2024
Associate Director(SAP SD S/4Hana) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Director - Enterprise Architect, APD Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Assoc. Dir. Platform Analytics Architecture Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Senior Manager Hyderabad (Office) Indien Operations CTS Marketing Sep 03, 2024
Tech Transfer Lead Schaftenau Österreich Operations Innovative Medicines Technical Operations Sep 03, 2024
Specialist - Quality Operations Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
Specialist – Quality Operations Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
Specialist – QOP Hyderabad (Office) Indien Operations Innovative Medicines Quality Sep 03, 2024
Quality Control Team Coordinator İstanbul Kurtköy Türkei Operations Innovative Medicines Quality Sep 03, 2024
Associate Director Enterprise Architect -IAM Barcelona Gran Vía Spanien Operations CTS Technology Transformation Sep 04, 2024
Manager, Health, Safety and Environment Cambridge (USA) USA Operations CTS Einrichtungen und Verwaltung Sep 04, 2024
QC Specialist I - Raw Materials Tuas South Avenue Singapur Operations Innovative Medicines Quality Sep 05, 2024
Process Unit Maintenance Engineer - Site Amiria Ägypten Operations Innovative Medicines Technical Operations Sep 05, 2024
Manufacturing Systems Expert Selangor Malaysia Operations Innovative Medicines Technical Operations Sep 05, 2024
E2E Planning Manager Warsaw Polen Operations Innovative Medicines Technical Operations Sep 06, 2024
Manager Data Science Hyderabad (Office) Indien Operations CTS Marketing Sep 06, 2024
Manufacturing Systems Expert Hyderabad (Office) Indien Operations Innovative Medicines Technical Operations Sep 06, 2024
Associate Director OPX Planning Prague Tschechische Republik Operations CTS Technology Transformation Sep 06, 2024
Admin Specialist Prague Tschechische Republik Operations CTS Beschaffung Sep 06, 2024
AS&T ekspert (m/ž/d) Ljubljana Slowenien Operations Innovative Medicines Quality Sep 09, 2024
Business process expert - Life Sciences(Regulatory, CSR, PV) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 09, 2024
Taktični planer / Tactical planner Mengeš Slowenien Operations CTS Technical Operations Sep 09, 2024
Associate Director – Conferencing Platform Services INSURGENTES Mexiko Operations CTS Technology Transformation Sep 09, 2024
Manager Data Science Hyderabad (Office) Indien Operations CTS Marketing Sep 09, 2024
Buyer with Italian Prague Tschechische Republik Operations Innovative Medicines Beschaffung Sep 15, 2024
Global Procurement Category Manager Biologics and Cell & Gene Prague Tschechische Republik Operations Innovative Medicines Beschaffung Sep 10, 2024
Enterprise Architecture and Integrations Director - Americas INSURGENTES Mexiko Operations CTS Technology Transformation Sep 10, 2024
Associate Director - LAN Sol. Architect (CZ, Spain, Mexico) Prague Tschechische Republik Operations CTS Technology Transformation Sep 11, 2024
Lehrling Elektrotechnik Schaftenau Österreich Operations Innovative Medicines Others Sep 11, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.